We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.65 | 2.30 | 3.00 | - | 0.00 | 13:55:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 5.03M | -2.44M | -0.0083 | -3.19 | 7.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/10/2024 12:18 | Give 'em a chance Dom, they did kindly release a profit warning last month. | barry evans | |
17/10/2024 12:13 | No News Available in the last month for PRM | dominiccummings | |
17/10/2024 12:12 | wasjobber - 05 Jul 2011 - 10:01:20 - 1612 of 93165 Proteome Sciences leading Alzheimer's technology. - PRM From the recent annual report. PRM are now in the last stage of their development, commercialization of their hugely valuable IP portfolio and products. Very interesting times lay ahead me thinks! | barry evans | |
17/10/2024 12:09 | mashman, Everything will look a lot better in a few months. Investors need to buy these while there is no demand. STRONG BUY | wasjobber | |
17/10/2024 11:43 | No change here I see | mashman | |
15/10/2024 05:32 | Was OBD one of Martin Diggle's too? | canaletto | |
14/10/2024 12:32 | Costs always outweigh sales,some business model they have put together.genius!!!!! | peverill | |
14/10/2024 11:49 | tmt revenues v total costs, I hope this helps 2024 H1 £1.85m total costs £3.92m 2023 £3.4m total costs £6.65m 2022 £4.16m + milestone total costs £6.05m 2021 £3.23m total costs £4.72m 2020 £3.27m total costs £4.2m | elpirata | |
14/10/2024 11:21 | 'selling well' why not just quote the tmt sales numbers of previous years to compare instead of waffling? | elpirata | |
14/10/2024 10:52 | I understand that TMT sales have been good, but that there is some delaying of buying awaiting the new, 32 plex versions. Makes sense to me - perhaps not to everyone! | goatherd | |
14/10/2024 10:41 | LOL anyone care to own up to that? | barry evans | |
14/10/2024 10:40 | I'm not sure what the 'thumbs down' represents; that it's not true or that it is true but an unwelcome observation? | jeffian | |
14/10/2024 10:27 | Eh? Total revenues, Proteomic services and TMT sales all showing year-on-year declines. "Selling well"? | jeffian | |
14/10/2024 10:18 | Selling well? worf.gif Time to let it go ffs. | monte1 | |
14/10/2024 10:16 | Don't forget that PRM not only has something to sell, which is selling well, and of which a new version is expected to sell even better. And potentially large amounts of royalties once someone, somewhere, infringes their very extensive patents; or gets a strike test onto the market. | goatherd | |
14/10/2024 09:37 | look no further than Pikey it mightnt fetch much, but at least obd have something to sell | elpirata | |
14/10/2024 09:13 | Indeed. OBD was arguably in a better position than this basket case too. | barry evans | |
11/10/2024 18:27 | I have a Google alert for TMT a lagging indicator of time spent here. The content nevet ever relates to PRM | alchemy | |
10/10/2024 04:41 | Funnily enough I still refer to some of them; and are pleased with their accuracy, although they were perhaps a touch on the low side. Aye, by about £20 a piece a share. How embarrassing. | barry evans |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions